Dr. Suhail Naseem Bukhari

Research Experiences To investigate and show the effectiveness of injecting RES-Q produced bone marrow mononuclear cells into ischemic tissue of patients with critical limb ischemia who are not candidates for amputation. ongoing at the Department of Vascular & Endovascular Surgery (principal investigator). in New Delhi, escorts the Heart Institute and Research Center. JTCS-002, a Phase IIa Randomized Double-Blind, Placebo Controlled Dose Escalation Study to Assess the Safety and Efficacy of JVS-100 Administered by Direct Intramuscular Injection to Cohorts of Adults with Critical Limb Ischemia, is designed to assess the safety and efficacy of JVS-100. To begin in the Department of Vascular and Endovascular Surgery as (Principle Investigator). in New Delhi, escorts the Heart Institute and Research Center. Clinical assessment of Cilastozol's effectiveness and safety in the treatment of intermittent claudication at Sir Ganga Ram Hospital in New Delhi. An examination of the past relationships between the ankle Brachial Index and Pulse Wave Velocity and several clinical risk factors for peripheral vascular disease. Sir Ganga Ram Hospital, Department of Vascular & Endovascular Surgery, New Delhi To Research the Deep Vein Thrombosis Prevalence in North India using the ABACUS - DVT Registry. Dissertation submitted in July 2002 in preparation for the Diplomate National Board Examination in General Surgery. Sentinel lymph node biopsy and axillary lymph nodes in breast cancer are correlated. Dr. S. Bukhari, Dr. Vijay Arora, and Dr. Bhalla served as co-guides.